Abstract
Introduction
The influence of enamel matrix derivative (EMD) on proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) was explored in high glucose (HG) microenvironment with interaction of Wnt/β-catenin pathway.
Materials and Methods
Extraction of BMSCs from Sprague–Dawley rats, culture, and identification were manifested. The cells were treated with different concentration of EMD in HG to figure out the most available concentration for proliferation and osteogenic differentiation. Then, observation of cell growth curve and cell cycle changes, and detection of Osterix, runt-related transcription factor 2 (Runx2), COL-I, early osteogenic indexes, Calcium salt deposition, and β-catenin protein in Wnt/β-catenin pathway were assured. After adding Wnt/β-catenin pathway inhibitor (XAV-939) in the cells with osteogenesis induction, detection of binding of β-catenin to Osterix was clarified.
Results
Via identification BMSCs cultured in vitro was qualified. Different concentrations of EMD could accelerate cell proliferation in HG and osteogenesis induction, and 75 μg/mL EMD had the best effect. The HG augmented BMSCs proliferation and the propidium iodide index of flow cytometry cycle was elevated in HG, which were strengthened via the EMD. After BMSCs’ osteogenesis induction, Osterix, Runx2, CoL-1, early osteogenic indexes, and calcium salt deposition were reduced, but elevated via EMD. β-Catenin was the lowest in the HG, but elevated after EMD. After addition of XAV-939, reduction of β-catenin and the downstream (Osterix and Runx2) were manifested. Detection of binding protein bands was in β-catenin and Osterix of the HG after EMD treatment.
Conclusion
EMD may facilitate the osteogenic differentiation of BMSCs via activating the Wnt/β-catenin pathway in HG.
Similar content being viewed by others
References
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149
Cole Joanne B, Florez Jose C (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 16:377–390
Dreyer H, Grischke J, Tiede C, Eberhard J, Schweitzer A, Toikkanen SE, Glöckner S, Krause G, Stiesch M (2018) Epidemiology and risk factors of peri-implantitis: a systematic review. J Periodont Res 53:657–681
Elangovan S, Brogden KA, Dawson DV, Blanchette D, Pagan-Rivera K, Stanford CM, Johnson GK, Recker E, Bowers R, Haynes WG, Avila-Ortiz G (2014) Body fat indices and biomarkers of inflammation: a cross-sectional study with implications for obesity and peri-implant oral health. Int J Oral Maxillofac Implants 29:1429–1434
Wang W, Zhang X, Zheng J, Yang J (2010) High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway. Mol Cell Biochem 338:115–122
Miron RJ, Sculean A, Cochran DL, Froum S, Zucchelli G, Nemcovsky C, Donos N, Lyngstadaas SP, Deschner J, Dard M, Stavropoulos A, Zhang Y, Trombelli L, Kasaj A, Shirakata Y, Cortellini P, Tonetti M, Rasperini G, Jepsen S, Bosshardt DD (2016) Twenty years of enamel matrix derivative: the past, the present and the future. J Clin Periodontol 43:668–683
Lyngstadaas SP, Wohlfahrt JC, Brookes SJ, Paine ML, Snead ML, Reseland JE (2009) Enamel matrix proteins; old molecules for new applications. Orthod Craniofac Res 12:243–253
Liu H, Wei LK, Jian XF, Huang J, Zou H, Zhang SZ, Yuan GH (2018) Isolation, culture and induced differentiation of rabbit mesenchymal stem cells into osteoblasts. Exp Ther Med 15:3715–3724
Luo Y, Zhang Y, Miao G, Zhang Y, Liu Y, Huang Y (2019) Runx1 regulates osteogenic differentiation of BMSCs by inhibiting adipogenesis through Wnt/β-catenin pathway. Arch Oral Biol 97:176–184
Roel N, Hans C (2017) Wnt/β-Catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985–999
Keila S, Nemcovsky CE, Moses O, Artzi Z, Weinreb M (2004) In vitro effects of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J Dent Res 83:134–138
Ikawa T, Akizuki T, Shujaa Addin A, Fukuba S, Stavropoulos A, Izumi Y (2019) Enamel matrix derivative in liquid form as adjunct to natural bovine bone grafting at buccal bone dehiscence defects at implant sites: an experimental study in beagle dogs. Clin Oral Implants Res 30:989–996
Shirakata Y, Eliezer M, Nemcovsky CE, Weinreb M, Dard M, Sculean A, Bosshardt DD, Moses O (2014) Periodontal healing after application of enamel matrix derivative in surgical supra/infrabony periodontal defects in rats with streptozotocin-induced diabetes. J Periodontal Res 49:101
Grazieli CM, Corrêa, Mirella, Gomes, Campos, Marcelo, Periodontology MJJo (2013) Histometric analysis of the effect of enamel matrix derivative on the healing of periodontal defects in rats with diabetes. J Periodontol 84:1309–1318
Takeda K, Mizutani K, Matsuura T, Kido D, Mikami R, Noda M, Buranasin P, Sasaki Y, Izumi Y (2018) Periodontal regenerative effect of enamel matrix derivative in diabetes. PLoS ONE 13:e0207201
Qian C, Zhu C, Yu W, Jiang X, Zhang F, Sun J (2016) Bone morphogenetic protein 2 promotes osteogenesis of bone marrow stromal cells in type 2 diabetic rats via the Wnt signaling pathway. Int J Biochem Cell Biol 80:143–153
Park SY, Kim KH, Park CH, Shin SY, Rhyu IC, Lee YM, Seol YJ (2018) Enhanced bone regeneration by diabetic cell-based adenoviral BMP-2 Gene therapy in diabetic animals. Tissue Eng Part A 24:930–942
Sun Y, Zhu Y, Liu X, Chai Y, Xu J (2020) Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis. Cell Prolif 53:e12866
Cheng L, Li Y, Xia Q, Meng M, Ye Z, Tang Z, Feng H, Chen X, Chen H, Zeng X, Luo Y, Dong Q (2021) Enamel matrix derivative (EMD) enhances the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Bioengineered 12:7033–7045
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Shi R, Huang Y, Ma C, Wu C, Tian W (2019) Current advances for bone regeneration based on tissue engineering strategies. Front Med 13:160–188
Tencerova M, Rendina-Ruedy E, Neess D, Færgeman N, Figeac F, Ali D, Danielsen M, Haakonsson A, Rosen CJ, Kassem M (2019) Metabolic programming determines the lineage-differentiation fate of murine bone marrow stromal progenitor cells. Bone Res 7:35
Zhang B, Liu N, Shi H, Wu H, Gao Y, He H, Gu B, Liu H (2016) High glucose microenvironments inhibit the proliferation and migration of bone mesenchymal stem cells by activating GSK3β. J Bone Miner Metab 34:140–150
Quan X, Jingyi F, Xiaolei Z (2021) Semaphorin3B promotes proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells in a high-glucose microenvironment. Stem Cells Int 2021:6637176
Shao J, Liu S, Zheng X, Chen J, Li L, Zhu Z (2021) Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway. BioFactors 47:80–92
Wang J, Wang B, Li Y, Wang D, Lingling E, Bai Y and Liu H (2013) High glucose inhibits osteogenic differentiation through the BMP signaling pathway in bone mesenchymal stem cells in mice. EXCLI J 12:584–597
Wyganowska-Swiatkowska M, Urbaniak P, Lipinski D, Szalata M, Kotwicka M (2017) Human gingival fibroblast response to enamel matrix derivative, porcine recombinant 213-kDa amelogenin and 53-kDa tyrosine-rich amelogenin peptide. Hum Cell 30:181–191
Guergana T, Brigitte S (2020) The double dealing of cyclin D1. Cell Cycle 19:163–178
Zhao Z, Zhao M, Xiao G, Franceschi RT (2005) Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther 12:247–253
Toshihisa K (2005) Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 95:445–453
Pérez-Campo FM, Santurtún A, García-Ibarbia C, Pascual MA, Valero C, Garcés C, Sañudo C, Zarrabeitia MT, Riancho JA (2016) Osterix and RUNX2 are transcriptional regulators of sclerostin in human bone. Calcif Tissue Int 99:302–309
Rossert J, Terraz C, Dupont S (2000) Regulation of type I collagen genes expression. Nephrol Dial Transplant 15:66–68
Ortuño MJ, Susperregui AR, Artigas N, Rosa JL, Ventura F (2013) Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions. Bone 52:548–556
Miron RJ, Chandad F, Buser D, Sculean A, Cochran DL, Zhang Y (2016) Effect of enamel matrix derivative liquid on osteoblast and periodontal ligament cell proliferation and differentiation. J Periodontol 87:91–99
McCarthy TL, Centrella M (2010) Novel links among Wnt and TGF-beta signaling and Runx2. Mol Endocrinol 24:587–597
Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–642
Li Z, Zhao H, Chu S, Liu X, Qu X, Li J, Liu D, Li H (2020) miR-124–3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats. In Vitro Cell Dev Biol Anim 56:723–734
Afifi MM, Austin LA, Mackey MA, El-Sayed MA (2014) XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles. Bioconjug Chem 25:207–215
Peng Y, Shi K, Wang L, Lu J, Li H, Pan S, Ma C (2013) Characterization of Osterix protein stability and physiological role in osteoblast differentiation. PLoS ONE 8:e56451
Funding
1. National Natural Science Foundation of China (Grant No. 81860192) (http://nsfc.gov.cn/). 2. Guiyang Scientific and Technological Program [(2017)3040].
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors disclosed no relevant relationships.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Meng, M., Xia, Q., Li, Y. et al. Enamel matrix derivative expedites osteogenic differentiation of BMSCs via Wnt/β-catenin pathway in high glucose microenvironment. J Bone Miner Metab 40, 448–459 (2022). https://doi.org/10.1007/s00774-022-01318-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-022-01318-6